Vaccine Efficacy Against Delta Variant: What We Know

does the vaccine stop spread of delta variant

The Delta variant of COVID-19 is highly contagious and transmissible, even in vaccinated individuals. While COVID-19 vaccines lower the likelihood of infection, they do not entirely prevent transmission of the Delta variant. Vaccinated individuals with a breakthrough infection of the Delta variant can spread the virus to others, similar to unvaccinated individuals. However, vaccines remain crucial in providing protection against severe illness, hospitalization, and death from COVID-19, including the Delta variant. To further enhance protection, vaccine manufacturers are investigating booster shots and updated vaccine doses specifically targeting the Delta variant.

Characteristics Values
Does the vaccine stop the spread of the Delta variant? No, the vaccine alone is not enough to prevent infection with and transmission of the Delta variant.
How does the Delta variant affect vaccinated people? The Delta variant can cause breakthrough infections in vaccinated people.
How does the Delta variant affect unvaccinated people? The Delta variant can cause reinfection in people who previously had a prior strain of COVID-19.
How does the Delta variant affect children? The risk of severe illness and death is low for children and hasn't changed with the Delta variant.
How does the Delta variant affect transmission? The Delta variant is more transmissible than previous variants, and vaccinated people with the Delta variant will transmit more often than with other variants.
How effective are vaccine boosters against the Delta variant? Published data on the effectiveness of vaccine boosters against the Delta variant are not yet available, but some pharmaceutical companies have announced that clinical trials support this perspective.
What measures can be taken to stop the spread of the Delta variant? In addition to vaccines, wearing masks in certain situations, such as indoor spaces with high local case numbers, can help slow the spread of the Delta variant.

cyvaccine

Vaccines lower the likelihood of infection

The Delta variant of COVID-19 is highly transmissible and can cause reinfections and breakthrough infections even in vaccinated individuals. However, vaccines do lower the likelihood of infection and remain crucial in the fight against the spread of COVID-19.

A study by Imperial College London researchers, published in The Lancet Infectious Diseases, evaluated community COVID-19 transmission and viral loads among 602 vaccinated and unvaccinated contacts of 471 mildly ill coronavirus outpatients aged 5 years and older. The study found that the secondary attack rate, or the percentage of contacts infected by an index patient, was 25% in fully vaccinated participants, compared to 38% in unvaccinated participants. This indicates that while the Delta variant can still be transmitted within households, the risk of transmission is lower among vaccinated individuals.

Furthermore, vaccines have been shown to reduce the severity of illness and protect against hospitalization and death. Early data suggest that vaccines are still more than 80% effective in preventing severe illness and death, even with the Delta variant. This is particularly important as the risk of severe illness and death from COVID-19 is higher for unvaccinated individuals.

To further enhance protection against the Delta variant, vaccine manufacturers have started developing and testing booster shots. Clinical trials by Pfizer have shown that receiving an additional booster dose of their COVID-19 vaccine after the initial two doses increases the amount of Delta variant antibodies fivefold in 18-to-55-year-olds and 11-fold in 65-to-85-year-olds. Moderna has also stated that an additional booster shot of its vaccine would be effective in keeping the Delta variant at bay.

While vaccines are crucial, additional measures such as wearing masks, especially in indoor spaces with high transmission rates, are also important in reducing the spread of the Delta variant.

cyvaccine

Vaccinated people can still spread the Delta variant

The Delta variant of COVID-19 is highly transmissible and can cause breakthrough infections even in vaccinated individuals. While the COVID-19 vaccines lower the likelihood of infection, vaccinated people can still transmit the virus, especially within households.

A study by Imperial College London researchers evaluated community COVID-19 transmission and viral loads among 602 vaccinated and unvaccinated contacts of mildly ill coronavirus outpatients. The study found that the secondary attack rate, or the percentage of contacts infected by an index patient, was 25% in fully vaccinated participants, indicating that the Delta variant can still spread among vaccinated individuals.

Additionally, Public Health England (PHE) stated that preliminary data showed that in Delta variant infections, the viral load of those who had received two doses of the vaccine was comparable to those who had not been vaccinated. This suggests that the ability of an infected person to spread the virus to others may be similar regardless of their vaccination status.

The risk of transmission is further highlighted by the highly contagious nature of the Delta variant. Its rapid spread has led countries like Australia to reinforce strict lockdowns as data suggests the variant is more infectious than previous strains and may bypass existing COVID-19 vaccines in some cases.

To reduce the spread of the Delta variant, it is crucial to combine vaccination with other measures such as wearing masks, especially in indoor spaces with high local case numbers. While vaccines provide significant protection against severe illness and hospitalization, their effectiveness in preventing transmission of the Delta variant is limited, emphasizing the need for additional precautions.

cyvaccine

Booster shots may improve protection

While the COVID-19 vaccines lower the likelihood of infection with the highly transmissible Delta variant, they do not completely prevent transmission. The Delta variant can cause breakthrough infections even in vaccinated individuals, and studies have shown that vaccinated and unvaccinated individuals exhibit similar peak viral loads, indicating ease of spread within households.

However, booster shots may improve protection against the Delta variant. According to Pfizer, receiving a third booster dose of their vaccine after the initial two doses increases Delta variant antibodies fivefold in 18-to-55-year-olds and 11-fold in 65-to-85-year-olds. Moderna has also stated that an additional booster shot of its vaccine would help keep the Delta variant at bay.

While the published data on the effectiveness of booster shots against the Delta variant is still limited, clinical trials by pharmaceutical companies support the perspective that booster shots improve protection. The ongoing booster trials aim to evaluate the safety and efficacy of the current vaccines in preserving the highest levels of protective efficacy against the Delta variant.

It is important to note that, even with the emergence of the Delta variant, the risk of severe illness and death, especially in children, remains low for vaccinated individuals. The vaccines are still more than 80% effective in preventing severe illness and death and continue to reduce transmission. Thus, the focus should also be on increasing vaccination rates and implementing additional measures, such as wearing masks, to stop the spread of COVID-19 and its variants.

cyvaccine

The importance of wearing masks

While the COVID-19 vaccines lower the likelihood of infection with the highly transmissible Delta variant, they do not completely stop its spread. The Delta variant can cause reinfection in people previously infected with a prior strain of COVID-19, and it can also infect those who are vaccinated.

Vaccines are still more than 80% effective at preventing severe illness and death and are reducing transmission. However, the highly transmissible nature of the Delta variant means that additional measures, such as wearing masks, are necessary to stop its spread.

Wearing masks is an important measure to slow the spread of the Delta variant. Masks act as a physical barrier, preventing the spread of respiratory droplets that may contain the virus. When an infected person wears a mask, it helps to block the release of these droplets into the air, reducing the risk of exposure for those around them. Similarly, masks protect the wearer by providing a barrier that blocks or filters out these droplets, reducing the chances of inhaling the virus.

The effectiveness of masks in reducing transmission has been demonstrated by their long-standing use in healthcare settings. For instance, doctors, especially surgeons, have worn masks since the 1920s to prevent the spread of germs to their patients.

In the context of the COVID-19 pandemic, wearing masks in public places, especially indoor spaces, is crucial to slowing the spread of the Delta variant. This is especially important when physical distancing is challenging or when individuals' vaccination status is unknown. By wearing masks, individuals can help protect themselves and others, reducing the overall transmission of the virus.

In addition to vaccination, wearing masks is a critical tool in the fight against the Delta variant. It is a simple yet effective measure that can significantly reduce the spread of the virus and protect individuals and communities.

cyvaccine

Vaccines reduce severe illness and hospitalisation

The Delta variant of COVID-19 is highly contagious and transmissible, even in vaccinated individuals. However, vaccines remain crucial in reducing severe illness and hospitalisation.

Vaccines offer significant protection against severe illness and hospitalisation caused by the Delta variant. While breakthrough infections can occur in vaccinated individuals, research suggests that vaccines effectively reduce the risk of severe disease and prevent the need for hospitalisation. For example, early data indicate that vaccines are over 80% effective at preventing severe illness and death, even with the Delta variant. This highlights the continued importance of vaccination in mitigating the impact of COVID-19 on healthcare systems.

Vaccines have been shown to reduce the severity of symptoms and lower the likelihood of hospitalisation. A study by Imperial College London researchers found that vaccinated individuals infected with the Delta variant had faster viral clearance and a lower risk of severe disease compared to unvaccinated individuals. Additionally, vaccinated individuals are less likely to require hospital care, reducing the strain on healthcare resources.

Furthermore, vaccines play a critical role in protecting vulnerable populations, such as the elderly, immunocompromised individuals, and those with underlying health conditions. These individuals are at a higher risk of severe disease and poor outcomes if infected. By getting vaccinated, they can significantly reduce their risk of severe illness and hospitalisation if exposed to the Delta variant.

While the Delta variant has been associated with an increased risk of reinfection, vaccines still provide a strong defence against severe disease. Vaccination, along with other preventive measures such as masking and physical distancing, remains the best strategy to protect individuals and communities from the harmful effects of the Delta variant.

In summary, while the Delta variant has challenged the effectiveness of vaccines in preventing infection, vaccines remain highly effective in reducing severe illness and hospitalisation. Vaccination continues to be a critical tool in the fight against COVID-19 and its variants, protecting individuals and communities from the most severe outcomes of the disease.

MRNA Vaccine: Does It Stay or Go?

You may want to see also

Frequently asked questions

No vaccine can completely stop the spread of the Delta variant. However, vaccines do lower the likelihood of infection and reduce transmission.

Studies have shown that the viral load of those who have been vaccinated is comparable to those who haven't. This means that the ability to infect others is the same, regardless of vaccination status.

According to Pfizer, receiving a booster dose of their COVID-19 vaccine increases the amount of Delta variant antibodies fivefold in 18-to-55-year-olds and 11-fold in 65-to-85-year-olds. Moderna has also stated that a booster shot will help keep the Delta variant at bay.

In addition to getting vaccinated, wearing masks in public will help reduce the spread of the Delta variant.

Written by
Reviewed by

Explore related products

Share this post
Print
Did this article help you?

Leave a comment